CTI Clinical Trial and Consulting announced the addition of a new business consultant and senior director of business development on Thursday – real-world evidence.
The Covington-based Contract Research Organization (CRO) has appointed Elizabeth “EJ” Fox as a business advisor. Prior to that, she worked for several years in health law at the Cincinnati Children’s Hospital.
She holds a law degree from the University of Cincinnati and a bachelor’s degree from the University of Dayton.
“We are very excited to have EJ on the Legal team,” said Jamie Meisenhelder, CTI General Counsel. “Your skills and experience will be valuable both for internal CTI and for our external partners. We look forward to your future successes in the department.”
In her new role at CTI, Fox will facilitate contracts between locations and sponsors, manage contracting for CTI’s Clinical Research Center, and advise on general business and employee relationships, the company said.
Victoria Snell joins the firm as Senior Director, Business Development, Real World Evidence.
She has over a decade of pharmaceutical and CRO experience including a number of leadership roles including Director Commercial Strategy and Operations at DRG Abacus, Commercial Lead Real World Evidence Solutions at IMS Health, Head of Business Development in the UK and Europe at the Economist Intelligence Unit and Director of Customer Strategy at Parexel.
“We are excited to announce the addition of Victoria to our global team,” said Joseph McCafferty, vice president, global business development and client management. “Your extensive experience will help fuel the achievements of the Real World Evidence division and we are confident it will have a positive impact on our team and sales performance goals for 2021.”
In her new role at CTI, Snell will be responsible for serving both current and prospective sponsors and connecting them with CTI’s Real World Evidence service offerings.
Top photo: Fox
Photo below: Snell